Parnassus Investments Lowered Holding in Mastercard Class A (MA) as Share Value Declined; Hl Financial Services Has Cut Intercept (ICPT) Holding by $608,454

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Logo

Parnassus Investments decreased its stake in Mastercard Inc. Class A (MA) by 0.07% based on its latest 2018Q3 regulatory filing with the SEC. Parnassus Investments sold 2,086 shares as the company’s stock declined 6.43% with the market. The institutional investor held 3.12M shares of the business services company at the end of 2018Q3, valued at $693.90M, down from 3.12M at the end of the previous reported quarter. Parnassus Investments who had been investing in Mastercard Inc. Class A for a number of months, seems to be less bullish one the $226.46 billion market cap company. The stock increased 0.74% or $1.63 during the last trading session, reaching $220.54. About 3.00 million shares traded. Mastercard Incorporated (NYSE:MA) has risen 32.53% since February 14, 2018 and is uptrending. It has outperformed by 32.53% the S&P500. Some Historical MA News: 09/04/2018 – Mastercard and Phillips 66 Drive Easier Payments with Masterpass; 15/03/2018 – Help from MasterCard and IBM on EU data rules; 03/05/2018 – Mastercard blames cryptocurrencies for slight drop in first-quarter growth; 16/05/2018 – CPI Card Group’s Suite of Metal Card Solutions Earns Bronze Stevie® Award in 2018 American Business Awards®; 02/05/2018 – MASTERCARD CFO MARTINA HUND-MEJEAN COMMENTS ON CONFERENCE CALL; 12/04/2018 – Mastercard and BJ’s Wholesale Club Enhance Checkout Experience for Shoppers with Masterpass; 16/04/2018 – AMBASSADOR MICHAEL FROMAN JOINS MASTERCARD AS VICE CHAIRMAN,; 07/03/2018 – MASTERCARD: LYONS LEAVES CO. TO START VENTURE FOR SERVICES; 26/04/2018 – The Town of Narragansett, Rhode Island Clerk’s Office Deploys SailPoint Over-the-Counter (OTC); 16/04/2018 – MASTERCARD HIRES OBAMA TRADE REP FROMAN IN STRATEGIC GROWTH

Hl Financial Services Llc decreased its stake in Intercept (ICPT) by 38.64% based on its latest 2018Q3 regulatory filing with the SEC. Hl Financial Services Llc sold 4,829 shares as the company’s stock declined 7.20% with the market. The institutional investor held 7,670 shares of the health care company at the end of 2018Q3, valued at $969,000, down from 12,499 at the end of the previous reported quarter. Hl Financial Services Llc who had been investing in Intercept for a number of months, seems to be less bullish one the $3.27 billion market cap company. The stock decreased 0.63% or $0.7 during the last trading session, reaching $110.35. About 605,437 shares traded or 19.37% up from the average. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) has risen 72.45% since February 14, 2018 and is uptrending. It has outperformed by 72.45% the S&P500. Some Historical ICPT News: 24/04/2018 – Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Bd of Directors; 05/04/2018 – INTERCEPT REPORTS CONCURRENT PLACEMENT OF COMMON SHRS; 26/03/2018 – INTERCEPT PHARMA SAYS LAWSUIT WAS FILED BY A STOCKHOLDER OF CO ON AUG 4, 2017 – SEC FILING; 24/04/2018 – Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Board of Directors; 02/05/2018 – Intercept Pharma Presenting at UBS Conference May 21; 09/03/2018 INTERCEPT PHARMACEUTICALS INC ICPT.O : WEDBUSH RAISES TARGET PRICE TO $256 FROM $253; 13/04/2018 – INTERCEPT COMMENTS ON SUBSTUDY FROM POISE PHASE 3 TRIAL; 22/04/2018 – DJ Intercept Pharmaceuticals Inc, Inst Holders, 1Q 2018 (ICPT); 04/04/2018 – INTERCEPT – EXPECTS NET SALES OF OCALIVA FOR QTR ENDED MARCH 31, TO BE SLIGHTLY LOWER THAN NET SALES OF OCALIVA FOR QTR ENDED DEC 31, 2017; 27/03/2018 – Intercept Pharma Presenting at Conference Tomorrow

Hl Financial Services Llc, which manages about $6.47 billion US Long portfolio, upped its stake in Monolithic Power Systems (NASDAQ:MPWR) by 2,923 shares to 45,295 shares, valued at $5.69M in 2018Q3, according to the filing. It also increased its holding in Spdr S&P Biotech Etf (XBI) by 53,476 shares in the quarter, for a total of 64,323 shares, and has risen its stake in Caterpillar Inc (NYSE:CAT).

Among 26 analysts covering Intercept Pharmaceuticals (NASDAQ:ICPT), 20 have Buy rating, 2 Sell and 4 Hold. Therefore 77% are positive. Intercept Pharmaceuticals had 90 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Outperform” rating by BMO Capital Markets given on Friday, September 22. Wedbush maintained Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) on Thursday, November 16 with “Buy” rating. Credit Suisse initiated it with “Outperform” rating and $200 target in Wednesday, March 30 report. The rating was maintained by Cowen & Co on Friday, September 22 with “Buy”. As per Thursday, June 1, the company rating was maintained by Credit Suisse. The company was upgraded on Tuesday, September 22 by Vetr. The stock has “Outperform” rating by Wedbush on Wednesday, June 1. As per Monday, February 4, the company rating was upgraded by Raymond James. Morgan Stanley initiated the shares of ICPT in report on Thursday, August 13 with “Underweight” rating. Cantor Fitzgerald initiated the stock with “Sell” rating in Wednesday, July 6 report.

Investors sentiment decreased to 1.25 in 2018 Q3. Its down 0.02, from 1.27 in 2018Q2. It fall, as 17 investors sold ICPT shares while 44 reduced holdings. 37 funds opened positions while 39 raised stakes. 18.21 million shares or 7.29% less from 19.65 million shares in 2018Q2 were reported. 5,000 are held by Tocqueville Asset Mngmt Limited Partnership. Axa holds 29,755 shares. Pinnacle Assoc Limited, a New York-based fund reported 153,358 shares. Deutsche Bank & Trust Ag holds 0.04% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 438,720 shares. Fmr Ltd Liability holds 0.06% or 4.43 million shares in its portfolio. Element Capital Mngmt Ltd Liability Com accumulated 2,704 shares. Federated Pa holds 0.03% or 85,025 shares in its portfolio. Alps Advsrs accumulated 0.04% or 52,318 shares. Birchview Lp has invested 0.35% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Teacher Retirement Sys Of Texas holds 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) or 2,445 shares. Altrinsic Advsrs Ltd Co holds 1.79% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 312,627 shares. 200 were accumulated by Sandy Spring National Bank & Trust. Captrust Advsrs accumulated 50 shares or 0% of the stock. C Worldwide Gru A S accumulated 1,446 shares or 0% of the stock. Macquarie Group Inc Limited invested in 35,561 shares or 0.01% of the stock.

More notable recent Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) news were published by: Globenewswire.com which released: “Intercept Announces NASH and PBC Program Updates – GlobeNewswire” on January 07, 2019, also 247Wallst.com with their article: “Why Gilead’s Pain Is Intercept’s Gain – 24/7 Wall St.” published on February 12, 2019, Seekingalpha.com published: “Intercept Pharma up 2% premarket on Oppenheimer upgrade – Seeking Alpha” on November 19, 2018. More interesting news about Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) were released by: Nasdaq.com and their article: “Intercept (ICPT) Gains on Solid Q2 Results, Ocaliva Recovers – Nasdaq” published on August 03, 2018 as well as Seekingalpha.com‘s news article titled: “Allergan downgraded on soft 2019 guidance in premarket analyst action – Seeking Alpha” with publication date: January 30, 2019.

Among 43 analysts covering Mastercard Incorporated (NYSE:MA), 38 have Buy rating, 0 Sell and 5 Hold. Therefore 88% are positive. Mastercard Incorporated had 148 analyst reports since July 21, 2015 according to SRatingsIntel. Cowen & Co maintained Mastercard Incorporated (NYSE:MA) rating on Wednesday, September 6. Cowen & Co has “Buy” rating and $137.0 target. The rating was maintained by Susquehanna with “Buy” on Monday, April 23. KeyBanc Capital Markets maintained the stock with “Overweight” rating in Friday, May 4 report. The stock of Mastercard Incorporated (NYSE:MA) earned “Overweight” rating by Morgan Stanley on Tuesday, September 19. As per Wednesday, October 11, the company rating was maintained by Cowen & Co. Bank of America downgraded the stock to “Neutral” rating in Tuesday, January 8 report. Wells Fargo maintained the shares of MA in report on Thursday, July 12 with “Outperform” rating. The stock has “Buy” rating by Evercore on Monday, September 7. The stock of Mastercard Incorporated (NYSE:MA) has “Overweight” rating given on Thursday, January 25 by Morgan Stanley. On Friday, February 2 the stock rating was maintained by KeyBanc Capital Markets with “Overweight”.

Since November 2, 2018, it had 1 insider buy, and 2 insider sales for $4.52 million activity. 5,000 shares were sold by Haythornthwaite Richard, worth $959,993 on Monday, December 17. On Tuesday, January 22 the insider McLaughlin Edward Grunde sold $4.04 million.

Parnassus Investments, which manages about $10.39B and $26.19B US Long portfolio, upped its stake in Starbucks Corp. (NASDAQ:SBUX) by 594,883 shares to 12.65 million shares, valued at $718.88 million in 2018Q3, according to the filing. It also increased its holding in Cummins Inc. (NYSE:CMI) by 500,000 shares in the quarter, for a total of 850,000 shares, and has risen its stake in Teleflex Inc. (NYSE:TFX).

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Institutional Positions Chart